Primary Tube Versus Trabeculectomy Study
Public ClinicalTrials.gov record NCT00666237. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT00666237
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- University of Miami
- Other
- Enrollment
- 242 participants
Conditions and interventions
Conditions
Interventions
- Mitomycin C Drug
- Trabeculectomy Procedure
- Tube shunt surgery Procedure
Drug · Procedure
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2008
- Primary completion
- Mar 31, 2021
- Completion
- Mar 31, 2021
- Last update posted
- Oct 18, 2022
2008 – 2021
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Davis Medical Center | Sacramento | California | 95817 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| Bascom Palmer Eye Institute | Miami | Florida | 33136 | — |
| Johns Hopkins | Baltimore | Maryland | 21290 | — |
| St. Louis University | St Louis | Missouri | 63104 | — |
| New York Eye and Ear Infirmary | New York | New York | 10003 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | — |
| University of Oklahoma | Oklahoma City | Oklahoma | 73104 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Glaucoma Associates of Texas | Dallas | Texas | 75231 | — |
| University of Texas, Houston | Houston | Texas | 77030 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00666237, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 18, 2022 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00666237 live on ClinicalTrials.gov.